| Lastest Insider Transactions Of NewAmsterdam Pharma Co N.V. ( NAMS ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| NAMS | NewAmsterdam Pharma Co N.V. | Topper James N | Directior | 2025-06-24 | Buy | 3,780 | 18.38 | 69,466 | 2025-06-26 19:41:52 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kling Douglas F | Chief Operating Officer | 2025-06-16 | Sell | 100,000 | 19.29 | 1,929,141 | 2025-06-18 16:50:44 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kling Douglas F | Chief Operating Officer | 2025-06-16 | Option Exercise | 100,000 | 10.20 | 1,019,709 | 2025-06-18 16:50:44 |
| NAMS | NewAmsterdam Pharma Co N.V. | Topper James N | Directior | 2025-06-16 | Buy | 8,584 | 19.50 | 167,381 | 2025-06-18 16:42:40 |
| NAMS | NewAmsterdam Pharma Co N.V. | LANGE LOUIS G | Directior | 2025-06-01 | Option Exercise | 68 | 0.00 | 0 | 2025-06-03 16:59:38 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kling Douglas F | Chief Operating Officer | 2025-05-15 | Sell | 100,000 | 0.00 | 0 | 2025-05-19 16:44:25 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kling Douglas F | Chief Operating Officer | 2025-05-15 | Option Exercise | 100,000 | 10.00 | 1,000,000 | 2025-05-19 16:44:25 |
| NAMS | NewAmsterdam Pharma Co N.V. | LANGE LOUIS G | Directior | 2025-05-01 | Option Exercise | 69 | 0.00 | 0 | 2025-05-02 16:55:45 |
| NAMS | NewAmsterdam Pharma Co N.V. | LANGE LOUIS G | Directior | 2025-04-14 | Option Exercise | 69 | 0.00 | 0 | 2025-04-21 17:41:13 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kling Douglas F | Chief Operating Officer | 2025-04-15 | Sell | 100,000 | 0.00 | 0 | 2025-04-17 17:41:07 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kling Douglas F | Chief Operating Officer | 2025-04-15 | Option Exercise | 100,000 | 10.00 | 1,000,000 | 2025-04-17 17:41:07 |
| NAMS | NewAmsterdam Pharma Co N.V. | Topper James N | Directior | 2025-03-26 | Buy | 1,135 | 22.49 | 25,521 | 2025-03-28 17:36:48 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kooij Louise Frederika | Chief Accounting Officer | 2025-03-26 | Option Exercise | 8,269 | 0.00 | 0 | 2025-03-28 17:29:55 |
| NAMS | NewAmsterdam Pharma Co N.V. | LANGE LOUIS G | Directior | 2025-03-26 | Option Exercise | 3,102 | 0.00 | 0 | 2025-03-28 17:24:45 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kastelein Johannes Jacob Pieter | Chief Scientific Officer | 2025-03-26 | Option Exercise | 45,481 | 0.00 | 0 | 2025-03-28 17:20:10 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kling Douglas F | Chief Operating Officer | 2025-03-26 | Sell | 16,539 | 0.00 | 0 | 2025-03-28 17:18:13 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kling Douglas F | Chief Operating Officer | 2025-03-26 | Option Exercise | 16,539 | 0.00 | 0 | 2025-03-28 17:18:13 |
| NAMS | NewAmsterdam Pharma Co N.V. | Davidson Michael H. | Chief Executive Officer | 2025-03-26 | Sell | 12,258 | 0.00 | 0 | 2025-03-28 17:15:18 |
| NAMS | NewAmsterdam Pharma Co N.V. | Davidson Michael H. | Chief Executive Officer | 2025-03-26 | Option Exercise | 38,394 | 0.00 | 0 | 2025-03-28 17:15:18 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kastelein Johannes Jacob Pieter | Chief Scientific Officer | 2025-03-24 | Option Exercise | 150,000 | 0.00 | 0 | 2025-03-26 16:27:40 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kling Douglas F | Chief Operating Officer | 2025-03-17 | Sell | 100,000 | 0.00 | 0 | 2025-03-19 17:29:57 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kling Douglas F | Chief Operating Officer | 2025-03-17 | Option Exercise | 100,000 | 1.19 | 118,880 | 2025-03-19 17:29:57 |
| NAMS | NewAmsterdam Pharma Co N.V. | Topper James N | Directior | 2025-03-04 | Buy | 4,005 | 21.02 | 84,203 | 2025-03-06 17:32:07 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kooij Louise Frederika | Chief Accounting Officer | 2025-03-04 | Sell | 150,000 | 20.37 | 3,055,500 | 2025-03-05 18:10:22 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kooij Louise Frederika | Chief Accounting Officer | 2025-03-04 | Option Exercise | 150,000 | 0.00 | 0 | 2025-03-05 18:10:22 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kling Douglas F | Chief Operating Officer | 2025-02-18 | Sell | 100,000 | 0.00 | 0 | 2025-02-20 17:24:36 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kling Douglas F | Chief Operating Officer | 2025-02-18 | Option Exercise | 100,000 | 0.00 | 0 | 2025-02-20 17:24:36 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kling Douglas F | Chief Operating Officer | 2025-01-29 | Sell | 70,441 | 0.00 | 0 | 2025-01-31 17:00:12 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kling Douglas F | Chief Operating Officer | 2025-01-29 | Option Exercise | 70,441 | 0.00 | 0 | 2025-01-31 17:00:12 |
| NAMS | NewAmsterdam Pharma Co N.V. | Somaiya Mayur Ian | Chief Financial Officer | 2025-01-27 | Sell | 61,883 | 0.00 | 0 | 2025-01-29 17:25:01 |
| NAMS | NewAmsterdam Pharma Co N.V. | Somaiya Mayur Ian | Chief Financial Officer | 2025-01-27 | Option Exercise | 61,883 | 9.26 | 573,037 | 2025-01-29 17:25:01 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kling Douglas F | Chief Operating Officer | 2025-01-27 | Sell | 129,559 | 0.00 | 0 | 2025-01-29 17:16:00 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kling Douglas F | Chief Operating Officer | 2025-01-27 | Option Exercise | 129,559 | 0.00 | 0 | 2025-01-29 17:16:00 |
| NAMS | NewAmsterdam Pharma Co N.V. | ForGrowth NAP B.V. | 10% Owner | 2024-12-30 | Sell | 29,846 | 25.54 | 762,174 | 2025-01-02 16:15:04 |
| NAMS | NewAmsterdam Pharma Co N.V. | ForGrowth NAP B.V. | 10% Owner | 2024-12-26 | Sell | 74,910 | 25.98 | 1,945,918 | 2024-12-30 16:15:03 |
| NAMS | NewAmsterdam Pharma Co N.V. | ForGrowth NAP B.V. | 10% Owner | 2024-12-20 | Sell | 91,068 | 25.58 | 2,329,520 | 2024-12-26 16:15:03 |
| NAMS | NewAmsterdam Pharma Co N.V. | ForGrowth NAP B.V. | 10% Owner | 2024-12-18 | Sell | 157,234 | 25.86 | 4,066,714 | 2024-12-20 16:25:29 |
| NAMS | NewAmsterdam Pharma Co N.V. | ForGrowth NAP B.V. | 10% Owner | 2024-12-16 | Sell | 115,480 | 25.95 | 2,996,156 | 2024-12-18 16:15:03 |
| NAMS | NewAmsterdam Pharma Co N.V. | ForGrowth NAP B.V. | 10% Owner | 2024-12-10 | Sell | 462,288 | 25.40 | 11,740,618 | 2024-12-12 16:15:06 |
| NAMS | NewAmsterdam Pharma Co N.V. | ForGrowth NAP B.V. | 10% Owner | 2024-11-15 | Sell | 41,803 | 25.07 | 1,047,876 | 2024-11-19 16:15:06 |
| NAMS | NewAmsterdam Pharma Co N.V. | ForGrowth NAP B.V. | 10% Owner | 2024-11-13 | Sell | 10,898 | 25.01 | 272,511 | 2024-11-15 16:36:13 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kooij Louise Frederika | Chief Accounting Officer | 2024-09-27 | Sell | 45,000 | 15.72 | 707,400 | 2024-10-01 17:23:55 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kooij Louise Frederika | Chief Accounting Officer | 2024-09-27 | Option Exercise | 45,000 | 0.00 | 0 | 2024-10-01 17:23:55 |
| NAMS | NewAmsterdam Pharma Co N.V. | Audet Juliette Berangere | Chief Business Officer | 2024-09-26 | Buy | 1,104 | 15.70 | 17,333 | 2024-09-30 17:22:34 |
| NAMS | NewAmsterdam Pharma Co N.V. | Davidson Michael H. | Chief Executive Officer | 2024-06-20 | Buy | 5,000 | 17.26 | 86,309 | 2024-06-24 08:30:04 |
| NAMS | NewAmsterdam Pharma Co N.V. | Topper James N | Directior | 2024-03-26 | Buy | 8,429 | 21.50 | 181,224 | 2024-03-28 16:30:34 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kastelein Johannes Jacob Pieter | Chief Scientific Officer | 2024-03-26 | Sell | 190,476 | 21.50 | 4,095,234 | 2024-03-27 16:30:16 |
| NAMS | NewAmsterdam Pharma Co N.V. | Kastelein Johannes Jacob Pieter | Chief Scientific Officer | 2024-03-26 | Option Exercise | 201,673 | 0.00 | 0 | 2024-03-27 16:30:16 |
| NAMS | NewAmsterdam Pharma Co N.V. | LANGE LOUIS G | Directior | 2024-02-13 | Buy | 5,000 | 19.00 | 95,000 | 2024-02-21 17:00:25 |
